BioAgri provides relatively low cost contract services for large quantity therapeutic protein manufacturing from transgenic chicken eggs for biomedical companies’ new drug development. BioAgri is manufacturing therapeutic proteins for Novartis and for its pre-clinical and clinical studies. Nosan Corporation (a subsidiary of Mitsubishi group in Japan) has become the sales representative to market BioAgri’s contract service in Japan.   BioAgri has formed a partnership with BioProMed, a Taiwanese biotech company and is seeking other major pharmaceutical companies worldwide to manufacture and market biogeneric therapeutic proteins.